Global Ophthalmoscopes Market Report to 2030: Rising Incidence of Eye Diseases Drives Growth

The “Ophthalmoscopes Market Size, Share & Trends Analysis Report By Type (Direct, Indirect), By Application (Diabetic Retinopathy, Macular Degeneration, Retinal Repair, Glaucoma), By End-use (Hospitals), By Region, And Segment Forecasts, 2023 – 2030″ report has been added to ResearchAndMarkets.com’s offering.

The global ophthalmoscopes market size is expected to reach USD 408.7 million by 2030 to expand at a CAGR of 6.6% from 2023 to 2030.

Companies Mentioned

  • Welch Allyn
  • Keeler Ltd.co
  • Zumax medical co. ltd
  • Albert Waeschle
  • Neitz Instruments Co., Ltd.
  • US Ophthalmic
  • Heine USA Ltd
  • HONSUN Group
  • Rudolf Riester GmbH
  • Dino-Lite Europe

The increasing technological advancements in ophthalmic devices, the growing prevalence of eye disorders, and increasing healthcare expenditure, particularly in emerging economies, are the key factors driving the growth of the ophthalmoscopes market.

Portable ophthalmoscopes are handheld devices used to examine the eye’s interior including the retina, optic disc, and blood vessels. The growing demand for portable ophthalmoscopes is increasing due to their ease of use and convenience. They are typically used by optometrists, eye doctors, and other medical professionals.

Additionally, advancement in technology is also a primary factor contributing to the demand for ophthalmoscopes. Advancements in artificial intelligence (AI) and machine learning are being incorporated into ophthalmoscopes, allowing for the automatic detection and diagnosis of eye diseases. AI-powered ophthalmoscopes can analyze images of the retina and optic nerve, identifying patterns and anomalies that may be indicative of eye diseases.

More than 2.9 million Americans aged 40 and older have low vision. Nearly 4.2 million Americans aged 40 and older are visually impaired. Approximately 8% of men and 0.5% of women with Northern European ancestry have the most common form of color blindness that makes it hard to see red or green. Such a rise in the incidence of eye disorders across the globe is anticipated to propel market growth.

The key players are involved in strategies, such as entering into product launches, collaborations & agreements, and mergers & acquisitions, to expand its geographical presence.

For instance, in August 2022, Swaraashi Netralya announced the launch ophthalmic devices including ophthalmoscope to identify eye concerns among adults as well as children’s. The Mirante SLO/OCT, a scanning laser ophthalmoscope used to capture high-quality color images was launched in India.

Ophthalmoscopes Market Report Highlights

  • Direct ophthalmoscopes accounted for the largest market share in 2022 owing to rising usage for examining the optic disc, retina, and other structures at the back of the eye
  • Based on application, glaucoma accounted for the largest market share of 31.8% in 2022 and is the leading cause of blindness in the U.S. and across the globe
  • Ophthalmic clinics are anticipated to register the fastest CAGR growth during the forecast period
  • North America accounted for the largest share of 32.3% in 2022 owing to the growing prevalence of eye diseases & disorders and rising advancement

Key Attributes:

Report Attribute Details
No. of Pages 100
Forecast Period 2022 – 2030
Estimated Market Value (USD) in 2022 $245.2 Million
Forecasted Market Value (USD) by 2030 $408.7 Million
Compound Annual Growth Rate 6.6%
Regions Covered Global

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Ophthalmoscopes Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.1.1. Growing incidence of eye diseases

3.2.1.2. Increasing technological advancements & government initiatives

3.2.1.3. Increasing awareness about eye health

3.2.1.4. Growing geriatric population

3.2.2. Market restraint analysis

3.2.2.1. Limited availability & technological limitations

3.2.2.2. High cost of ophthalmoscopes

3.3. Dental Regeneration: Market Analysis Tools

Chapter 4. Ophthalmoscopes Market: Type Estimates & Trend Analysis

Chapter 5. Ophthalmoscopes Market: Application Estimates & Trend Analysis

Chapter 6. Ophthalmoscopes Market: End-use Estimates & Trend Analysis

Chapter 7. Ophthalmoscopes Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

8.1. Company Profiles

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version